Translational Medicine
Open Access

Genomic analysis for early indication of cochlear implantation

2^nd International Conference on Translational & Personalized Medicine

August 05-07, 2013 Holiday Inn Chicago-North Shore, IL, USA

Hans Peter Zenner

Scientific Tracks Abstracts: Transl Med

Abstract :

Molecular personalized medicine has to goal, to identify those patients, who respond in a positive or negative (non-responder, no wanted effect) manner to a specific therapy. Using genomic analyses of the functional proteins otoferlin, connexin26, KCNQ4 or Usher genes personalized plays an increasing role in the indication of cochlear implants for newborn babies. Instead of waiting for a non-development of language, application allows for early implantation and thus for earlier language development.